KorMedi
  • Beauty
  • Health
  • Lifestyle
  • Medicine
  • Biowatch
  • Column
  • Kormedi.com TV
  • Notice
KorMedi
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice

Search results for "new drug candidates"

Home
LigaChemBio Receives Milestone from Czech Sotio Biotech

LigaChemBio Receives Milestone from Czech Sotio Biotech

LigaChem Biosciences announced on the 9th that it will receive milestone payments based on successful product development under the antibody-drug...
02/09/2026, 04:32 ET
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval

High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval

Since the World Health Organization recommended the use of obesity medications for adults last December, the market is expected to heat up even...
02/06/2026, 03:39 ET
Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?

Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?

Cholera vaccine specialist Eubiologics has shown strong performance growth, recording net profits for two consecutive...
02/05/2026, 04:06 ET
Pharmaceutical Industry Establishes Successive R&BD Subsidiaries... Is Yuhan Corporation Joining?

Pharmaceutical Industry Establishes Successive R&BD Subsidiaries... Is Yuhan Corporation Joining?

Yuhan Corporation recently announced plans to establish a specialized subsidiary for 'Research and Business Development...
01/22/2026, 19:11 ET
When Ovarian Cancer is Detected, 70% Have Peritoneal Metastasis... Due to the Cancer Cells' 'Cunning Strategy'?

When Ovarian Cancer is Detected, 70% Have Peritoneal Metastasis... Due to the Cancer Cells' 'Cunning Strategy'?

Ovarian cancer is often found at stages 3 or 4, with a high mortality rate of about 80%.
01/06/2026, 16:01 ET
Dr. Han Jin-hwan, Formerly of Merck (MSD), Appointed Head of New Drug Research Institute at Ligand Pharmaceuticals

Dr. Han Jin-hwan, Formerly of Merck (MSD), Appointed Head of New Drug Research Institute at Ligand Pharmaceuticals

Ligand Pharmaceuticals announced on the 5th that it has recruited Dr. Han Jin-hwan, formerly of Merck, as the head of...
01/04/2026, 14:33 ET
Previous123
KorMedi
  • Business registration number: 214-87-97051
  • Press registration number: Seoul A 00292
  • Registration date: 2006-11-30
  • Title: Kormedi.com
  • Representative number: 02-2052-8200
  • Address: 41, Mapo-daero 4da-gil, Mapo-gu, Seoul, Henkel Tower (2nd Floor, Mapo Tower)
  • Issue date: November 30, 2006
  • Publisher and Editor-in-Chief: Seong Ju Lee
  • Youth Protection Officer: Simon Hong
  • Company Introduction
  • Privacy Policy
  • Terms of Service
  • Youth Protection Policy
  • Email Collection Refusal
  • Advisory Board
  • Advertising and Partnership Inquiries

Kormedi.com does not provide medical advice, diagnosis or treatment.

Multilingual content on this site is generated using AI-based translation and may contain errors or differences in interpretation. For legal or medical matters, please refer to the original language version.

© 2026 KoreaMedicare. All Rights Reserved.Powered by 팡고링고
Languages

ENGLISH

English (US)

ASIAN

Монгол日本語Tiếng ViệtBahasa Indonesia中文 (简体, 中国大陆)

EUROPEAN

РусскийEspañol (España)Français (France)

MIDDLE_EAST_AFRICA

العربية